The depletion of CAFs by ProAgio consequentially decreases tumor immunosuppressive effects, e.g., an increase in CD8+ T-cells and a decrease in CD4+ Treg cells and MDSCs in lung tumors. This evidence concerns the gene CD4 and neoplasm.